Australian university working on Zika vaccine

By REUTERS
February 2, 2016 13:26

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The University of South Australia said on Tuesday it was working on a vaccine for the Zika virus with Australian biotech Sementis Ltd, a day after the World Health Organization declared the mosquito-borne disease an international public health emergency.

Sanofi SA also said on Tuesday it had launched a project to develop a vaccine against the virus.

So far, small biotech companies and universities have taken the initiative to develop a vaccine, although Britain's GlaxoSmithKline Plc has said it is studying whether its vaccine technology can be used against the virus.

Zika, a close cousin of dengue and chikungunya, causes mild fever and rash. An estimated 80 percent of those infected suffer no symptoms, making it difficult for pregnant women to know whether they have been infected.

The University of South Australia and Sementis have already developed a chikungunya vaccine, which is currently in the process of being clinically tested.

Related Content

Breaking news
July 21, 2018
More than 100 report sexual misconduct by late Ohio State doctor

By REUTERS